未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Impact of oral nutritional support adherence on muscle strength, body composition, and general health status in gastrointestinal cancer patients: ONMUS study 口服营养支持依从性对胃肠道癌患者肌肉力量、身体成分及整体健康状况的影响：ONMUS研究 Ozveren, Ahmet; Cil, Timucin; Bicakli, Derya Hopanci; Gultekin, Gamze; Dogan, Dilek; Zengin, Canan; Bilici, Ahmet; Sabir, Songul; Ercelep, Ozlem; Eksi, Feyzanur; Selcukbiricik, Fatih; Yilmaz, Meltem; Ergene, Gozde; Tatli, Ali Murat; Aksoy, Feray Karsli; Uysal, Ozen; Dizdar, Omer; Yildirim, Hasan Cagri; Ozmen, Nesrin; Ozturk, Seniz; Sanli, Ulus Ali; Karabulut, Bulent 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Prognostic value of inflammatory-nutritional indexes and HALP score in advanced stage NSCLC treated with first-line TKI 晚期非小细胞肺癌一线TKI治疗中炎症-营养指标及HALP评分的预后价值 Ogul, Ali; Solmaz, Ali Alper; Birsenogul, Ilhan; Coskun, Yunus; Koyuncu, Mahmut Bakir; Yetisir, Abdullah Evren; Buyuksimsek, Mahmut; Tohumcuoglu, Mert; Turker, Mehmet; Gurbuz, Mustafa; Duman, Berna Bozkurt; Cil, Timucin 分享 收藏
Prognostic Significance of the Combined Albumin-To-Alkaline Phosphatase Ratio (AAPR) and Haemoglobin-Albumin-Lymphocyte-Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy: A New Prognostic Combined Risk Scoring Koseci, Tolga; Seyyar, Mustafa; Kidi, Mehmet Mutlu; Biter, Sedat; Eser, Kadir; Kefeli, Umut; Nayir, Erdinc; Duman, Berna Bozkurt; Mete, Burak; Demirhindi, Hakan; Cil, Timucin 分享 收藏
POD1UM-304: Phase III study of retifanlimab plus platinum-based chemotherapy (Chemo) as first-line (1L) therapy for nonsquamous or squamous metastatic nonesmall cell lung cancer (mNSCLC) POD1UM-304：瑞他法尼单抗联合铂类化疗（Chemo）作为非鳞状或鳞状转移性非小细胞肺癌（mNSCLC）的一线（1L）治疗的III期研究 Lu, S.; Vynnychenko, O.; Kulyaba, Y.; Kuchava, V.; Ibrahim, A.; Moiseenko, F. V.; Arslan, C.; Nguyen, D. T.; Zhang, M.; Petrovic, M. D.; Cicin, I.; Bibichadze, K.; Cil, T.; Cornfeld, M.; Tian, C.; Munteanu, M.; Sette, C. V. D. M.; Bondarenko, I. 分享 收藏
KEYNOTE-859 update: Pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer KEYNOTE-859更新：帕博利珠单抗联合化疗治疗晚期HER2阴性胃或胃食管结合部（G/GEJ）癌 Ryu, M. H.; Rha, S. Y.; Wyrwicz, L. S.; Weber, P. E. Yanez; Bai, Y.; Lee, J.; Herrero, F. Rivera; Alves, G. V.; Garrido, M.; Shiu, K-K.; Gonzalez Fernandez, M.; Li, J.; Lowery, M. A.; Cil, T.; Cruz, F.; Oh, D-Y.; Yin, L.; Bordia, S.; Bhagia, P.; Qin, S. 分享 收藏
Nivolumab plus Ipilimumab in Microsatellite-Instability-High Metastatic Colorectal Cancer Andre, Thierry; Elez, Elena; Van Cutsem, Eric; Jensen, Lars Henrik; Bennouna, Jaafar; Mendez, Guillermo; Schenker, Michael; de la Fouchardiere, Christelle; Limon, Maria Luisa; Yoshino, Takayuki; Li, Jin; Lenz, Heinz-Josef; Manzano Mozo, Jose Luis; Tortora, Giampaolo; Garcia-Carbonero, Rocio; Dahan, Laetitia; Chalabi, Myriam; Joshi, Rohit; Goekkurt, Eray; Braghiroli, Maria Ignez; Cil, Timucin; Cela, Elvis; Chen, Tian; Lei, Ming; Dixon, Matthew; Abdullaev, Sandzhar; Lonardi, Sara 分享 收藏
Enteral nutrition consensus report from KEPAN: Indications, choice, practical application, and follow-up Doganay, Mutlu; Akcay, Kezban; Cil, Timucin; Dag, Birgul; Demirag, Kubilay; Demirkan, Kutay; Gundogdu, Riza Haldun; Gunduz, Hasan Murat; Parsak, Cem Kaan; Topcuoglu, Mehmet Akif; Turkoglu, Melda; Abbasoglu, Osman 分享 收藏
Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study Artac, M.; Cubukcu, E.; Bozkurt, O.; Bilici, A.; Celik, S.; Ozcelik, M.; Oven, B.; Simsek, E.; Geredeli, C.; Karaca, M.; Cil, T.; Harputluoglu, H.; Sendur, M.; Turk, H.; Kefeli, U.; Alacacioglu, A.; Tural, D.; Sakin, A.; Karadurmus, N.; Cevik, D.; Dane, F.; Gumus, M. 分享 收藏
First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis Isikdogan, A.; Turk, H.; Bilir, C.; Sendur, M.; Karabulut, B.; Artac, M.; Cicin, I.; Geredeli, C.; Alacacioglu, A.; Kefeli, U.; Harputluoglu, H.; Bozkurt, O.; Cubukcu, E.; Tural, D.; Sakin, A.; Cil, T.; Dane, F.; Cevik, D.; Arslan, C.; Karadurmus, N.; Gumus, M.; Yalcin, S. 分享 收藏
Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study Eser, Kadir; Onder, Arif Hakan; Sezer, Emel; Cil, Timucin; Inal, Ali; Ozturk, Banu; Ercolak, Vehbi; Duman, Berna Bozkurt; Celik, Halil; Koseci, Tolga; Kesen, Oguzhan 分享 收藏
分享 收藏
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
.png){kind=icon}
分享.png){kind=icon}
收藏